OrthoPediatrics Corp. $KIDS Shares Acquired by Wasatch Advisors LP

Wasatch Advisors LP grew its holdings in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 56.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 515,677 shares of the company’s stock after purchasing an additional 186,357 shares during the period. Wasatch Advisors LP’s holdings in OrthoPediatrics were worth $9,865,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the business. Russell Investments Group Ltd. grew its stake in OrthoPediatrics by 433.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after buying an additional 1,139 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in OrthoPediatrics by 5,226.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock valued at $46,000 after buying an additional 2,561 shares during the last quarter. Caption Management LLC purchased a new stake in OrthoPediatrics in the third quarter valued at about $54,000. BNP Paribas Financial Markets boosted its holdings in OrthoPediatrics by 60.2% in the third quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after acquiring an additional 1,235 shares in the last quarter. Finally, State of Wyoming boosted its holdings in OrthoPediatrics by 189.7% in the fourth quarter. State of Wyoming now owns 6,822 shares of the company’s stock worth $121,000 after acquiring an additional 4,467 shares in the last quarter. Institutional investors and hedge funds own 69.05% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on KIDS. Weiss Ratings upgraded shares of OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 5th. BTIG Research reiterated a “buy” rating and issued a $24.00 target price on shares of OrthoPediatrics in a research note on Friday, May 1st. Needham & Company LLC boosted their target price on shares of OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Truist Financial set a $22.00 price target on shares of OrthoPediatrics in a research note on Wednesday, August 5th. Finally, TD Cowen reaffirmed a “buy” rating on shares of OrthoPediatrics in a report on Monday, June 15th. Nine equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $25.89.

OrthoPediatrics Trading Up 2.6%

Shares of OrthoPediatrics stock opened at $24.86 on Thursday. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.78 and a quick ratio of 2.17. The firm has a fifty day moving average price of $19.83 and a 200 day moving average price of $18.02. OrthoPediatrics Corp. has a 1 year low of $14.42 and a 1 year high of $25.01. The stock has a market cap of $649.09 million, a PE ratio of -14.80 and a beta of 0.98.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share for the quarter, topping the consensus estimate of ($0.30) by $0.04. The company had revenue of $70.51 million for the quarter, compared to the consensus estimate of $68.21 million. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%. Equities research analysts predict that OrthoPediatrics Corp. will post -1.14 earnings per share for the current year.

OrthoPediatrics Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.